Andarix Pharmaceuticals Competitors and Similar CompaniesClear all

Andarix Pharmaceuticals's competitors and similar companies include MPC Therapeutics, Eureka Therapeutics, Iksuda Therapeutics and Partner Therapeutics.

	Andarix Pharmaceuticals Andarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond.	MPC Therapeutics MPC Therapeutics is a company that develops drugs for mitochondria.	Eureka Therapeutics Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.	Iksuda Therapeutics Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.	Partner Therapeutics Partner Therapeutics is developing and commercializing cancer medicines and combination therapies.
Founding Date	Founding Date N/A	Founding Date 2018	Founding Date 2006	Founding Date 2007	Founding Date 2017
Type	Type Private	Type Private	Type Private	Type Private	Type Private
Tags	Tags Healthcare drug development oncology therapy	Tags Healthcare drug development oncology therapy	Tags Healthcare bioengineering drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare drug development oncology therapy
Locations	Locations HQ	Locations Geneva, CH HQ	Locations Emeryville, US HQ	Locations Newcastle upon Tyne, GB HQ Newton, US	Locations Lexington, US HQ Boston, US Lynnwood, US
Employees	Employees N/A	Employees 7	Employees 432% decrease	Employees 43	Employees 189
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 1.6m (over 3 years ago)	Latest funding round $ 45m (about 6 years ago)	Latest funding round $ 47m (almost 5 years ago)	Latest funding round $ 60m (over 8 years ago)
Total funding raised	Total funding raised N/A	Total funding raised $ 1.6m	Total funding raised $ 130.4m	Total funding raised $ 47m	Total funding raised $ 60m